Search Results - Patel, Hamina

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Enhanced T-lymphocyte infiltration in a desmoid tumor of the thoracic wall in a young woman treated with intratumoral injections of the oncolytic peptide LTX-315: a case report

    Enhanced T-lymphocyte infiltration in a desmoid tumor of the thoracic wall in a young woman treated with intratumoral injections of the oncolytic peptide LTX-315: a case report by Jebsen, Nina Louise, Apelseth, Torunn Oveland, Haugland, Hans Kristian, Rekdal, Øystein, Patel, Hamina, Gjertsen, Bjørn Tore, Jøssang, Dag Eirik

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors

    Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors by Spicer, James, Marabelle, Aurélien, Baurain, Jean-Francois, Jebsen, Nina Louise, Jøssang, Dag Erik, Awada, Ahmad, Kristeleit, Rebecca, Loirat, Delphine, Lazaridis, George, Jungels, Christiane, Brunsvig, Paal, Nicolaisen, Berit, Saunders, Andrew, Patel, Hamina, Galon, Jérôme, Hermitte, Fabienne, Camilio, Ketil André, Mauseth, Brynjar, Sundvold, Vibeke, Sveinbjørnsson, Baldur, Rekdal, Øystein

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Abstract CT010: A phase I study of the oncolytic peptide LTX-315 generates de novo T-cell responses and clinical benefit in patients with advanced sarcoma

    Abstract CT010: A phase I study of the oncolytic peptide LTX-315 generates de novo T-cell responses and clinical benefit in patients with advanced sarcoma by Baaurain, Jean-Francois, Jungels, Christiane, Kristeleit, Rebecca S., Jossang, Dag E., Jebsen, Nina L., Rekdal, Øystein, Sveinbjornsson, Baldur, Gjerstad, Vibeke S., Brunsvig, Paal, Galon, Jerome, Hermitte, Fabienne, Patel, Hamina

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Abstract CT069: A Phase I study of the oncolytic peptide LTX-315 generates de novo T-cell responses and clinical benefit in patients with advanced melanoma

    Abstract CT069: A Phase I study of the oncolytic peptide LTX-315 generates de novo T-cell responses and clinical benefit in patients with advanced melanoma by Marabelle, Aurelien, Baurain, Jean-Francois, Awada, Ahmad, Kristeleit, Rebbecca S., Loirat, Delphine, Jossang, Dag E., Jebsen, Nina L., Sveinbjornsson, Baldur, Rekdal, Øystein, Gjerstad, Vibeke S., Brunsvig, Paal, Galon, Jerome, Hermitte, Fabienne, Patel, Hamina, Spicer, James

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Moderate whisky consumption in combination with an evening meal reduces tryptophan availability to the brain but does not influence performance in healthy volunteers

    Moderate whisky consumption in combination with an evening meal reduces tryptophan availability to the brain but does not influence performance in healthy volunteers by Markus, C. Rob, Sierksma, Aafje, Verbeek, Cees, van Rooijen, Jan J. M., Patel, Hamina J., Brand, A. Nico, Hendriks, Henk F. J.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Effect of Cytochrome P450 3A4 Inducers on the Pharmacokinetic, Pharmacodynamic and Safety Profiles of Bortezomib in Patients with Multiple Myeloma or Non-Hodgkin’s Lymphoma

    Effect of Cytochrome P450 3A4 Inducers on the Pharmacokinetic, Pharmacodynamic and Safety Profiles of Bortezomib in Patients with Multiple Myeloma or Non-Hodgkin’s Lymphoma by Hellmann, Andrzej, Rule, Simon, Walewski, Jan, Shpilberg, Ofer, Feng, Huaibao, van de Velde, Helgi, Patel, Hamina, Skee, Donna M., Girgis, Suzette, Louw, Vernon J.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Effect of the Cytochrome P450 3A4 Inducers, Rifampicin and Dexamethasone, on the Pharmacokinetic, Pharmacodynamic and Safety Profile of Bortezomib In Patients with Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL)

    Effect of the Cytochrome P450 3A4 Inducers, Rifampicin and Dexamethasone, on the Pharmacokinetic, Pharmacodynamic and Safety Profile of Bortezomib In Patients with Multiple Myeloma... by Hellmann, Andrzej, Rule, Simon A., Walewski, Jan, Shpilberg, Ofer, Feng, Huaibao, van de Velde, Helgi, Patel, Hamina, Skee, Donna M, Girgis, Suzette, Louw, Vernon

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Enhanced T-lymphocyte infiltration in a desmoid tumor of the thoracic wall in a young woman treated with intratumoral injections of the oncolytic peptide LTX-315: A case report

    Enhanced T-lymphocyte infiltration in a desmoid tumor of the thoracic wall in a young woman treated with intratumoral injections of the oncolytic peptide LTX-315: A case report by Jebsen, Nina Louise, Apelseth, Torunn Oveland, Haugland, Hans Kristian, Rekdal, Øystein, Patel, Hamina, Gjertsen, Bjørn Tore, Jøssang, Dag Eirik

    Request full text
    Article
    Save to List
    Saved in:

Search Tools: